Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006.

Gunnar Juliusson,Karin Karlsson,Vladimir Lazarevic,Anders Wahlin,Mats Brune,Petar Antunovic,Åsa Rangert Derolf,Hans Hägglund,Holger Karbach,Sören Lehmann,Lars Möllgård,Dick Stockelberg,Helene Hallböök,Martin Höglund

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006.

2011

Gunnar Juliusson
Karin Karlsson
Vladimir Lazarevic
Anders Wahlin
Mats Brune
Petar Antunovic
Åsa Rangert Derolf
Hans Hägglund
Holger Karbach
Sören Lehmann
Lars Möllgård
Dick Stockelberg
Helene Hallböök
Martin Höglund

BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, but outcome is hampered by toxicity. Population-based data avoid patient selection and may theref ...

Keywords:

Performance status
Population
Pathology
Hematopoietic stem cell transplantation
Myeloid
Stem cell
Oncology
Acute leukemia
Toxicity
Transplantation
Medicine
Internal medicine
Immunology
Leukemia
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations